In an effort to increase global access to diagnostic science, information, and services, Secaucus-based Quest Diagnostics, working with other international diagnostic services providers, launches the Global Diagnostics Network (GDN). Quest Diagnostics plans to use the initiative of diagnostic laboratories to benefit patients, healthcare providers, referring practitioners, pharmaceutical innovators, government agencies, non-governmental agencies, and academic institutions.
The Network of participating providers view diagnostics as a primary precedent to health care. “As we met with regional lab leaders over the past year, it became clear that we can accelerate the development and delivery of advanced diagnostics and diagnostic insights by bringing together our peers and sharing best practices,” explained Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics, in a press statement.
Initial projects at the labs will include a global launch platform for high-quality companion diagnostics and creating a network of pathogen preparedness to quicken research and response to infectious diseases. Over time, additional projects will be introduced based on regional and global priorities. Currently, countries involved in the initiative are China, Brazil, South Korea, Australia, Germany, and multiple Middle Eastern regions.
“The GDN collaboration will open up new opportunities by removing silos around unique knowledge and resources,” stated Carrie Eglinton Manner, Senior Vice President, Advanced Diagnostics, Quest Diagnostics. “We see this as a pragmatic approach to driving growth and excellence for all network members, while providing customers global access to innovations in diagnostics science, information, and service delivery.”
